Osiris' mechanical tentacles connected to the main thinker array of the Mountain Array Apothecary Sanctuary and began to systematically analyze the compensatory mechanisms formed in the bodies of the Rapid Expeditionary soldiers.
With a deep understanding of the original physiological design of the Space Marines, his processing core rapidly compared a series of key parameters.
"The core of the problem lies in the compensatory imbalance of the neuroendocrine system," Osiris stated the analysis results in a calm, synthesized voice.
The holographic projection displayed the physiological data stream of the test soldiers in real time. "The long-term lack of the regulatory function of the Sus-an Membrane led to the hypothalamus-pituitary-adrenal axis being in a state of continuous hyperactivity."
Alvaro pulled up the corresponding hormone monitoring charts to verify: "The data shows that these warriors' basal cortisol levels are about 40 percent higher than the standard value."
"This is precisely the key factor that triggers the rejection reaction," Apothecary Togal added, pointing to the functional readings of the newly implanted organ. "The overactive endocrine system cannot adapt to the normal regulatory rhythm brought about by the Sus-an Membrane."
Based on these findings, Osiris formulated a phased treatment plan. He first selected three soldiers from the Rapid Expeditionary Army with relatively mild symptoms as the first batch of patients to receive treatment.
These soldiers only exhibited intermittent fluctuations in body temperature and mild motor coordination difficulties, and had not yet shown serious organ dysfunction.
The treatment took place in a sterile medical pod adjacent to the sanctuary. Osiris personally operated the sophisticated drug delivery system while simultaneously monitoring the subject's physiological signal changes in real time through a multi-channel neural interface.
"Begin infusing the neuromodulation inhibitor, with the initial dose set at 70% of the standard value," Osiris instructed the assisting apothecary attendant.
The transparent liquid medicine was slowly injected into the first soldier's circulatory system through a precision pump.
At the same time, Osiris began to adjust the environmental parameters: "The temperature of the medical cabin was lowered by two degrees Celsius to partially simulate the thermoregulation function of Sus-an Membrane."
During the subsequent treatment, Osiris continued to monitor the dynamic changes of various physiological indicators.
Based on real-time feedback data, he made minor adjustments to the treatment plan every twenty minutes.
"Soldier number 742's thyroid hormone levels are beginning to normalize," Magos Weiss reported the latest monitoring results. "Heart rate variability has improved significantly, reaching 15 percent."
The apothecary Togal examined the tissue biopsy sample: "The concentration of inflammatory factors has decreased significantly, and the process of cell necrosis has been effectively contained."
"Start the gene seed calibration program, using the alpha band frequency." Osiris input the updated parameters into the main control system.
Inside the medical pod, a special bio-energy field began to act on the test soldiers.
This technology draws on the theory of gene seed synergy in Ms. Astartes' original design, aiming to promote the integration of the newly implanted organ with the host's gene seed.
After six hours of treatment, the three soldiers' physiological indicators gradually stabilized.
Hormone levels returned to normal, the rejection response of nerve tissue was significantly reduced, and the body's thermoregulation function gradually recovered.
"The acute rejection reaction has been brought under control," Osiris summarized the treatment results, "but this is only a phase of success. The reconstruction of the compensatory mechanism will require a longer period."
Togal meticulously recorded the complete treatment data: "At least we've verified the correctness of the treatment approach. The health of these soldiers has stopped deteriorating."
"This approach can be extended to other mild cases. However, for severe cases, the treatment strategy may need to be adjusted." Magos Weiss began organizing the treatment records.
Osiris disconnected the medical equipment. "Next, we need to observe the patient for 24 hours. If the condition stabilizes, we can begin the second round of treatment."
The indicator light in the medical pod changed from a warning red to a stable green, signifying that the first batch of soldiers who received treatment were temporarily out of danger.
The technical priests within the sanctuary began preparing the necessary medical equipment and drug reserves for the subsequent treatment cycles.
After stabilizing the acute symptoms of most of the recruits, Osiris began to address the root cause of the rejection reaction.
His treatment plan is divided into two distinct phases.
The first phase focuses on adjusting the soldiers' existing physiological state.
Osiris developed personalized medication formulas based on the specific circumstances of each soldier.
He used specially formulated neuromodulators to balance the functional activity of the hypothalamus-pituitary-adrenal axis, while simultaneously mimicking some functions of the Sus-an Membrane through environmental regulation.
"Continuously monitor cortisol and adrenaline levels," Osiris instructed the attending apothecary. "Maintain thyroxine levels at 85 percent of the standard range."
During the treatment, Osiris noticed significant differences in the different soldiers' responses to the medication.
Some soldiers' hormone levels stabilized quickly after taking the medication, while others required repeated dose adjustments.
He paid special attention to cases with more stubborn compensation mechanisms and established an independent treatment file for each soldier.
While regulating hormones, Osiris began to treat the already implanted organs.
He uses low-intensity bioenergy fields to gently stimulate organ tissues, promoting their connection with the host's neural network.
This process requires extremely precise control; the intensity of the energy field must be just right—enough to activate organ function without triggering new rejection reactions.
"Current organ activity has reached 60% of the expected value," Wissage reported the latest data. "Neural connectivity stability has improved by 25% compared to before treatment."
The second phase of the work involves cultivating new, custom-made organs.
Osiris extracted gene samples from each soldier and began customized cultivation in the biological laboratory of the Mountain Array.
Unlike the previous standard template, this time he fine-tuned the gene sequences of Sus-an Membrane and Beon's salivary glands based on each soldier's unique physiological parameters.
"The cultivation process needs to be synchronized with the soldiers' genetic seeds," Osiris explained to the apothecary. "This is to ensure that the new organs are fully accepted."
While waiting for the new organs to be cultivated, Osiris continued to optimize the soldiers' physiological condition.
He gradually reduced the drug dosage and observed the soldiers' ability to self-regulate.
Most soldiers' endocrine systems began to show normal self-regulation, indicating that the compensatory mode was being gradually eliminated.
"Soldier number 763's hormone levels have remained stable for 72 consecutive hours," Togal reported. "Preparations for organ transplantation can begin."
Osiris checked the soldier's latest data and confirmed that his physiological condition had indeed met the criteria for surgery.
At the same time, the biological laboratory also completed the cultivation of customized organs with corresponding numbers.
"Begin the first customized organ transplant," Osiris ordered.
The surgery was performed inside the sterile medical compartment of the Mountain Array.
Osiris personally performed the surgery, and his robotic arm completed the implantation of the new organ with astonishing precision.
Throughout the process, the life monitoring system showed that the soldier's physiological indicators remained stable.
With the successful implantation of the first custom-made organ, Osiris' treatment plan has been initially validated.
The next step is to observe the integration of the new organ with the host, which will determine the direction of subsequent treatment.